AbbVie is a North Chicago-based biopharmaceutical company that develops and sells medicines across various therapeutic areas, employing 50,000 staff since its IPO in January 2013. Key products include Humira, Botox, and NX-13 for ulcerative colitis.
ABBV has been in the news recently: AbbVie has submitted a Biologics License Application for TrenibotE, a botulinum neurotoxin, supported by data from over 2,100 patients. The company's stock has increased by 6% since last quarter, but it has seen a decline of 14% this month prior to its earnings report.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
